- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 19, 2023
Product Development
Will a gene therapy approval in DMD harm innovation?
A deep pipeline of gene therapy candidates follows Sarepta’s SRP-9001, meaning patients may face a tough choice
BioCentury | Aug 11, 2016
Targets & Mechanisms
Niche for the aged
Targeting integrin β1 or fibronectin for muscle repair in the aged
Items per page:
1 - 2 of 2